US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...

Surgeons are removing up to 10 kilograms of excess skin from patients who have lost major amounts of weight, amid a booming interest in body-contouring operations.

Wegovy has gained attention as a powerful weight loss medication, especially for those struggling with obesity. However, if ...

The FDA recently announced that Novo Nordisk’s semaglutide GLP-1 medication (Ozempic and Wegovy) is no longer in short supply ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...